Literature DB >> 15583744

Human platelets contain forms of factor V in disulfide-linkage with multimerin.

Catherine P M Hayward1, Nola Fuller, Shilun Zheng, Frédéric Adam, Samira B Jeimy, Ian Horsewood, Mary Ann Quinn-Allen, William H Kane.   

Abstract

Factor V is an essential cofactor for blood coagulation that circulates in platelets and plasma. Unlike plasma factor V, platelet factor V is stored complexed with the polymeric alpha-granule protein multimerin. In analyses of human platelet factor V on nonreduced denaturing multimer gels, we identified that approximately 25% was variable in size and migrated larger than single chain factor V, the largest form in plasma. Upon reduction, the unusually large, variably-sized forms of platelet factor V liberated components that comigrated with other forms of platelet factor V, indicating that they contained factor V in interchain disulfide-linkages. With thrombin cleavage, factor Va heavy and light chain domains, but not B-domains,were liberated from the components linked by interchain disulfide bonds, indicating that the single cysteine in the B-domain at position 1085 was the site of disulfide linkage. Since unusually large factor V had a variable size and included forms larger than factor V dimers, the data suggested disulfide-linkage with another platelet protein, possibly multimerin. Immunoprecipitation experiments confirmed that unusually large factor V was associated with multimerin and it remained associated in 0.5 M salt. Moreover, platelets contained a subpopulation of multimerin polymers that resisted dissociation from factor V by denaturing detergent and comigrated with unusually large platelet factor V, before and after thrombin cleavage. The disulfide-linked complexes of multimerin and factor V in platelets, which are cleaved by thrombin to liberate factor Va, could be important for modulating the function of platelet factor V and its delivery onto activated platelets. Factor Va generation and function from unusually large platelet factor V is only speculative at this time.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15583744     DOI: 10.1160/TH03-02-0123

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  6 in total

Review 1.  The intersection of protein disulfide isomerase and cancer associated thrombosis.

Authors:  Jack D Stopa; Jeffrey I Zwicker
Journal:  Thromb Res       Date:  2018-04       Impact factor: 3.944

2.  Location of the multimerin 1 binding site in coagulation factor V: an update.

Authors:  Samira B Jeimy; Mary Ann Quinn-Allen; Nola Fuller; William H Kane; Catherine P M Hayward
Journal:  Thromb Res       Date:  2008-05-02       Impact factor: 3.944

3.  Mouse chromosome 17 candidate modifier genes for thrombosis.

Authors:  Qila Sa; Erika Hart; Joseph H Nadeau; Jane L Hoover-Plow
Journal:  Mamm Genome       Date:  2010-08-11       Impact factor: 2.957

4.  Molecular characterization of 3 factor V mutations, R2174L, V1813M, and a 5-bp deletion, that cause factor V deficiency.

Authors:  Keiko Shinozawa; Kagehiro Amano; Takashi Suzuki; Asashi Tanaka; Kenji Iijima; Hoyu Takahashi; Hiroshi Inaba; Katsuyuki Fukutake
Journal:  Int J Hematol       Date:  2007-12       Impact factor: 2.490

5.  EMILIN2 (Elastin microfibril interface located protein), potential modifier of thrombosis.

Authors:  Qila Sa; Jane L Hoover-Plow
Journal:  Thromb J       Date:  2011-05-11

Review 6.  Multimerin-1 and cancer: a review.

Authors:  Mareike G Posner
Journal:  Biosci Rep       Date:  2022-02-25       Impact factor: 3.840

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.